Search

Marisha L Godek

from Portland, CT
Age ~53
Get Report
Also known as:
Marisha Loren Godek, Marisha L Godel
Phone and address:
24 Old Homestead Vlg, Portland, CT 06480
Related to:
Susan Godek, 77
Connected to:
Benjamin P Godek, 33Brian T Godek, 53Diane M Godek, 65Gail J Godek, 58Andrew R Godeke, 32Steven M Godeke, 62Gary W Godel, 79Keith V Godel, 63Linda C Godel, 75Michael R Godel, 71

Marisha Godek Phones & Addresses

  • 24 Old Homestead Vlg, Portland, CT 06480
  • 2201 Orchard Pl, Fort Collins, CO 80521 (970) 221-5701
  • 265 Davis St, Hamden, CT 06517 (203) 230-8583
  • Ellington, CT
  • North Haven, CT
  • Denver, CO
  • Raleigh, NC
  • Boulder, CO
  • 265 Davis St, Hamden, CT 06517 (970) 206-4851

Work

Company: Covidien 2008 Position: Senior research scientist

Education

Degree: PhD School / High School: Colorado State University 2001 to 2006 Specialities: Cell & Molecular Biology

Skills

Biomaterials • Cell Culture • Medical Devices • Cell Biology • R&D • Biochemistry • Molecular Biology • Product Development • Glp • Lifesciences • Biomedical Engineering • Public Speaking • Biocompatibility • Microbiology • Research and Development • Pre Clinical Studies • Professional Mentoring • Guest Lecturing • Project Management • Product Launch • In Vitro • Immunology • Tissue Culture • Microscopy • Protein Chemistry • Gel Electrophoresis • Protein Expression • Western Blotting • Pcr • Toxicology • Polymer Chemistry • Cancer Biology • Immunoblotting • Nanobiotechnology • Surface Chemistry • Macrophages • Inflammation • Nucleic Acid Extraction • Digital Photography • Technical Writing • Consulting • Life Sciences • Commercialization • Hospitals • In Vivo

Interests

Civil Rights and Social Action • Education • Science and Technology • Animal Welfare • Arts and Culture • Health

Industries

Medical Devices

Resumes

Resumes

Marisha Godek Photo 1

Medical Science Liaison

View page
Location:
24 Old Homestead Vlg, Portland, CT 06480
Industry:
Medical Devices
Work:
Covidien since 2008
Senior Research Scientist
Colorado State University 2006 - 2008
Associate Research Director
Education:
Colorado State University 2001 - 2006
PhD, Cell & Molecular Biology North Carolina State University 1999 - 2001
MS, Chemistry
Skills:
Biomaterials
Cell Culture
Medical Devices
Cell Biology
R&D
Biochemistry
Molecular Biology
Product Development
Glp
Lifesciences
Biomedical Engineering
Public Speaking
Biocompatibility
Microbiology
Research and Development
Pre Clinical Studies
Professional Mentoring
Guest Lecturing
Project Management
Product Launch
In Vitro
Immunology
Tissue Culture
Microscopy
Protein Chemistry
Gel Electrophoresis
Protein Expression
Western Blotting
Pcr
Toxicology
Polymer Chemistry
Cancer Biology
Immunoblotting
Nanobiotechnology
Surface Chemistry
Macrophages
Inflammation
Nucleic Acid Extraction
Digital Photography
Technical Writing
Consulting
Life Sciences
Commercialization
Hospitals
In Vivo
Interests:
Civil Rights and Social Action
Education
Science and Technology
Animal Welfare
Arts and Culture
Health

Publications

Us Patents

Nanoparticle Delivery Vehicle

View page
US Patent:
20030147966, Aug 7, 2003
Filed:
Jul 10, 2002
Appl. No.:
10/192393
Inventors:
Stefan Franzen - Apex NC, US
Daniel Feldheim - Cary NC, US
Alexander Tkachenko - Raleigh NC, US
Marisha Godek - Fort Collins CO, US
Joseph Ryan - Raleigh NC, US
Miles Anderson - Raleigh NC, US
International Classification:
A61K048/00
C12N015/85
A61K009/16
A61K009/50
US Classification:
424/491000, 514/044000, 435/455000
Abstract:
A nanoparticle delivery vehicle, comprising a nanoparticle, an active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising a nanoparticle having a diameter of about 30 nm or less, an active agent and a nuclear localization signal; and contacting a target cell with the nanoparticle delivery vehicle, whereby an active agent is delivered to the nucleus of a target cell. Another representative method includes providing a nanoparticle delivery vehicle comprising a nanoparticle having a diameter greater than or equal to about 30 nm, an active agent and a nuclear localization signal; and contacting a target cell with the nanoparticle delivery vehicle, whereby an active agent is delivered to the cytoplasm of a cell.

Nanoparticle Delivery Vehicle

View page
US Patent:
20080199529, Aug 21, 2008
Filed:
Feb 15, 2008
Appl. No.:
12/032292
Inventors:
Stefan Franzen - Apex NC, US
Daniel L. Feldheim - Cary NC, US
Alexander G. Tkachenko - Raleigh NC, US
Marisha L. Godek - Fort Collins CO, US
Joseph A. Ryan - Raleigh NC, US
Miles F. Anderson - Raleigh NC, US
International Classification:
A61K 31/7088
A61K 9/51
A61K 38/16
A61K 38/02
A61P 43/00
US Classification:
424497, 514 44, 424490, 514 12, 514 2
Abstract:
A nanoparticle delivery vehicle, comprising a nanoparticle, an active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising a nanoparticle having a diameter of about 30 nm or less, an active agent and a nuclear localization signal; and contacting a target cell with the nanoparticle delivery vehicle, whereby an active agent is delivered to the nucleus of a target cell. Another representative method includes providing a nanoparticle delivery vehicle comprising a nanoparticle having a diameter greater than or equal to about 30 nm, an active agent and a nuclear localization signal; and contacting a target cell with the nanoparticle delivery vehicle, whereby an active agent is delivered to the cytoplasm of a cell.

Device For Monitoring Physiological Parameters In Vivo

View page
US Patent:
20120273548, Nov 1, 2012
Filed:
Apr 3, 2012
Appl. No.:
13/438012
Inventors:
Yong Ma - Cheshire CT, US
Nelson Scarborough - Andover MA, US
Marisha Godek - Fort Collins CO, US
Rohan Shah - New Haven CT, US
James Power - Madison CT, US
Nilay Mukherjee - Lexington MA, US
Frank Viola - Sandy Hook CT, US
Edward Mckenna - Boulder CO, US
Shannon Campbell - Boulder CO, US
International Classification:
A61B 17/115
US Classification:
2271761
Abstract:
A monitoring system is disclosed for in vivo monitoring of preselected physiological parameters associated with acute and/or chronic tissue compromise or failure in one or multiple tissue/organ sites in real time. In one method, a body portion of a surgical stapling device is positioned adjacent a first tissue section, an anvil assembly adapted to engage the body portion is positioned adjacent a second tissue section, and a monitoring device is positioned adjacent the first and/or second tissue sections. The monitoring device includes a sensor adapted to measure a preselected physiological parameter and a transmitter for transmitting signal to an extracorporeal receiving unit. The surgical stapling device is fired to mechanically secure the first and second tissue sections with at least one staple and the preselected physiological parameter is monitored via the information transmitted from the monitoring device to the receiving unit.

Device For Monitoring Physiological Parameters In Vivo

View page
US Patent:
20170245809, Aug 31, 2017
Filed:
May 12, 2017
Appl. No.:
15/593737
Inventors:
- Mansfield MA, US
Nelson Scarborough - Andover MA, US
Marisha Godek - Portland CT, US
Rohan Shah - New Haven CT, US
James Power - Crownsville MD, US
Nilay Mukherjee - Burlington MA, US
Frank Viola - Sandy Hook CT, US
Edward Mckenna - Boulder CO, US
Shannon Campbell - Boulder CO, US
International Classification:
A61B 5/00
A61B 5/07
A61B 17/115
A61B 17/06
A61B 17/064
A61B 5/145
A61B 17/11
Abstract:
A monitoring system is disclosed for in vivo monitoring of preselected physiological parameters associated with acute and/or chronic tissue compromise or failure in one or multiple tissue/organ sites in real time. In one method, a body portion of a surgical stapling device is positioned adjacent a first tissue section, an anvil assembly adapted to engage the body portion is positioned adjacent a second tissue section, and a monitoring device is positioned adjacent the first and/or second tissue sections. The monitoring device includes a sensor adapted to measure a preselected physiological parameter and a transmitter for transmitting signal to an extracorporeal receiving unit. The surgical stapling device is fired to mechanically secure the first and second tissue sections with at least one staple and the preselected physiological parameter is monitored via the information transmitted from the monitoring device to the receiving unit.
Control profile
Marisha L Godek from Portland, CT, age ~53 Get Report